NeoGenomics is a Florida-based medical laboratory that delivers cancer diagnostics, clinical trials and related services for pharmaceutical companies in the United States.Read more
Ambry Genetics is one of NeoGenomics's top competitors. Ambry Genetics was founded in 1999, and its headquarters is in Aliso Viejo, California. Like NeoGenomics, Ambry Genetics also works within the Biotechnology sector. Ambry Genetics has 600 fewer employees than NeoGenomics.
LabCorp is NeoGenomics's #2 rival. LabCorp was founded in 1905 in Burlington, North Carolina. LabCorp operates in the Biotechnology industry. LabCorp generates $14.9B more revenue than NeoGenomics.
NeoGenomics's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 964.4M. Over the last four quarters, NeoGenomics's revenue has grown by 32.8%. Specifically, in Q1 2021's revenue was $115.5M; in Q4 2020, it was $126M; in Q3 2020, it was $125.4M; in Q2 2020, NeoGenomics's revenue was $87M.